Regulation of membrane type-1 matrix metalloproteinase activity by proprotein convertases

Molecular Biology of the Cell

Volumn 11, Issue 7, 2000, Pages 2387-2401

  Yana, Ikuo ^a   Weiss, Stephen J ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME PRECURSOR; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ARTICLE; ENZYME ACTIVATION; ENZYME REGULATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROCESSING; TISSUE REGENERATION;

ANIMALIA;

EID: 0033944447     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.11.7.2387     Document Type: Article

References (55)

1. Belien, A.T.J., Paganetti, P.A., and Schwab, M.E. (1999). Membranetype 1 matrix metalloproteinase (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J. Cell Biol. 144, 373-384.
2. 1-antitrypsin Portland inhibits processing of precursors mediated by proprotein convertases primarily within the constitutive secretory pathway. J. Biol. Chem. 272, 26210-26218.
3. Botos, I., Scapozza, L., Zhang, D., Liotta, L.A., and Meyer, E.F. (1996). Batimastat, a potent matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding. Proc. Natl. Acad. Sci. USA 39, 2749-2754.
4. Cao, J., Drews, M., Lee, H.M., Conner, C., Bahou, W.F., and Zucker, S. (1998). The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A. J. Biol. Chem. 273, 34745-34752.
5. Cao, J., Rehemtulla, A., Bahou, W., and Zucker, S. (1996). Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain. J. Biol. Chem. 271, 30174-30180.
6. Cao, J., Rehemtulla, A., Conner, C., Drews, M., Bahou, W., and Zucker, S. (1999). Furin directly processes pro-gelatinase A within the secretory pathway of cells. Proc. Am. Assoc. Cancer Res. 40, 3432A.
7. Chenard, M.-P., Lutz, Y., Mechine-Neuville, A., Stoll, I., Bellocq, J.-P., Rio, M.-C., and Basset, P. (1999). Presence of high levels of MT1-MMP protein in fibroblastic cells of human invasive carcinomas. Int. J. Cancer 82, 208-212.
8. Cui, Y., Jean, F., Thomas, G., and Christian, J.L. (1998). BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development. EMBOJ. 17, 4735-4743.
9. d'Ortho, M.-P., Stanton, H., Butler, M., Atkinson, S.J., Murphy, G., and Hembry, R.M. (1998) M.T1-M.M.P. on the cell surface causes focal degradation of gelatin films. FEBS Lett. 421, 159-164.
10. Decroly, E., Benjannet, S., Savaria, D., and Seidah, N.G. (1997). Comparative functional role of PC7 and furin in the processing of the HIV envelope glycoprotein gp160. FEBS Lett. 405, 68-72.
11. Duguay, S.J., Milewski, W.M., Young, B.D., Nakayama, K., and Steiner, D.F. (1997). Processing of wild-type and mutant proinsulin-like growth factor-IA by subtilisin-related proprotein convertases. J. Biol. Chem. 272, 6663-6670.
12. Fernandez-Larrea, J., Merlos-Suarez, A., Urena, J.M., Baselga, J., and Arribas, J. (1999). A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-α to the cell surface. Mol. Cell 3, 423-433.
13. Gu, M., Rappaport, J., and Leppla, S.H. (1995). Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1. FEBS Lett. 365, 95-97.
14. Hallenberger, S., Bosch, V., Angliker, H., Shaw, E., Klenk, H.-D., and Garten, W. (1992). Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature 360, 358-361.
15. Hiraoka, N., Allen, E., Apel, I.J., Gyetko, M.R., and Weiss, S.J. (1998). Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95, 365-377.
16. Holmbeck, K., et al. (1999). M.T1-M.M.P-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99, 81-92.
17. Hotary, K., Allen, E., Punturieri, A., Yana, I., and Weiss, S.J. (2000). Regulation of cell invasion and morphogenesis in a 3-dimensional type 1 collagen matrix by membrane-type matrix metalloproteinase 1, 2 and 3. J. Cell Biol. (in press).
18. Inocencio, N.M., Sucic, J.F., Moehring, J.M., Spence, M.J., and Moehring, T.J. (1997). Endoprotease activities other than furin and PACE4 with a role in processing of HIV-I gp160 glycoproteins in CHO-K1 cells. J. Biol. Chem. 272, 1344-1348.
19. Itoh, Y., Kajita, M., Kinoh, H., Mori, H., Okada, A., and Seiki, M. (1999). Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase. J. Biol. Chem. 274, 34260-34266.
20. 1-antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent. Proc. Natl. Acad. Sci. USA 95, 7293-7298.
21. Kazes, I., Delarue, F., Hagege, J., Bouzhir-Sima, L., Rondeau, E., Sraer, J.-D., and Nguyen, G. (1998). Soluble latent membrane-type 1 matrix metalloprotease secreted by human mesangial cells is activated by urokinase. Kidney Int. 54, 1976-1984.
22. Kurschat, P., Zigrino, P., Nischt, R., Breitkopf, K., Steurer, P., Klein, C.E., Krieg, T., and Mauch, C. (1999). Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J. Biol. Chem. 274, 21056-21062.
23. Lehti, K., Lohi, J., Valtanen, H., and Keski-Oja, J. (1998). Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem. J. 334, 345-353.
24. Logeat, F., Bessia, C., Brou, C., LeBail, O., Jarriault, S., Seidah, N.G., and Israel, A. (1998). The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc. Natl. Acad. Sci. USA 95, 8108-8112.
25. Lohi, J., Lehti, K., Westermarck, J., Kahari, V.-M., and Keski-Oja, J. (1996). Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur. J. Biochem. 239, 239-247.
26. Lund, L.R., Romer, J., Bugge, T.H., Nielsen, B.S., Frandsen, T.L., Degen, J.L., Stephens, R.W., and Dano, K. (1999). Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J. 17, 4645-4656.
27. Malloy, S.S., Thomas, L., VanSlyke, J.K., Stenberg, P.E., and Thomas, G. (1994). Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from the cell surface. EMBO J. 13, 18-33.
28. Maquoi, E., Noel, A., Frankenne, F., Angliker, H., Murphy, G., and Foidart, J.-M. (1998). Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor. FEBS Lett. 424, 262-266.
29. Nagase, H., and Woessner, J.F., Jr. (1999). Matrix metalloproteinases. J. Biol. Chem. 274, 21491-21494.
30. Nakahara, H., Howard, L., Thompson, E.W., Sato, H., Seiki, M., Yeh, Y., and Chen, W.-T. (1997). Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc. Natl. Acad. Sci. USA 94, 7959-7964.
31. Nakayama, K. (1997). Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem. J. 327, 625-635.
32. Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., and Okada, Y. (1997). Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272, 2446-2451.
33. Okada, A., Tomasetto, C., Lutz, Y., Bellocq, J.-P., Rio, M.-C., and Basset, P. (1997). Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J. Cell Biol. 137, 67-77.
34. Okumura, Y., Sato, H., Seiki, M., and Kido, H. (1997). Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. FEBS Lett. 402, 181-184.
35. Pei, D. (1999). Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J. Biol. Chem. 274, 8925-8932.
36. Pei, D., and Weiss, S.J. (1995). Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375, 244-247.
37. Pei, D., and Weiss, S.J. (1996). Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271, 9135-9140.
38. Posthaus, H., Dubois, C.M., Laprise, M.-H., Grondin, F., Suter, M.M., and Muller, E. (1998). Proprotein cleavage of E-cadherin by furin in baculovirus over-expression system: potential role of other convertases in mammalian cells. FEBS Lett. 438, 306-310.
39. Rajavashisth, T.B., et al. (1999). Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J. Biol. Chem. 274, 11924-11929.
40. Rice, W.G., and Weiss, S.J. (1990). Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. Science 249, 178-181.
41. Santavicca, M., Noel, A., Angliker, H., Stoll, I., Segain, J.-P., Anglard, P., Chretien, M., Seidah, N., and Basset, P. (1996). Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases. Biochem. J. 315, 953-958.
42. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370, 61-65.
43. Schlondorff, J., and Blobel, C.P. (1999). Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J. Cell Sci. 322, 3603-3617.
44. Stanton, H., Gavrilovic, J., Atkinson, S.J., d'Ortho, M.-P., Yamada, K.M., Zardi, L., and Murphy, G. (1998). The activation of proMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of M.T1-M.M.P. (M.M.P-14) to a 45 kDa form. J. Cell Sci. 111, 2789-2798.
45. Strongin, A.Y., Collier, I., Bannikov, G., Marmer, B.L., Grant, G.A., and Goldberg, G.I. (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase. J. Biol. Chem. 270, 5331-5338.
46. Toth, M., Gervasi, D.C., and Fridman, R. (1997). Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells. Cancer Res. 57, 3159-3167.
47. Urena, J.M., Merlos-Suarez, A., Baselga, J., and Arribas, J. (1999). The cytoplasmic carboxy-terminal amino acid determines the subcellular localization of proTGF-α and membrane type matrix metalloprotease (M.T1-M.M.P). J. Cell Sci. 112, 773-784.
48. Vollenweider, F., Benjannet, S., Decroly, E., Savaria, D., Lazure, C., Thomas, G., Cretien, M., and Seidah, N.G. (1996). Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases. Biochem. J. 314, 521-532.
49. Weiss, S.J., Peppin, G., Ortiz, X., Ragsdale, C., and Test, ST. (1985). Oxidative autoactivation of latent collagenase by human neutrophils. Science 227, 747-749.
50. Wesley, C.L., Rehemtulla, A., and Kaufman, R.J. (1993). PACE/furin can process the vitamin K-dependent pro-factor IX precursor within the secretory pathway. J. Biol. Chem. 268, 8458-8465.
51. Will, H., Atkinson, S.J., Butler, G.S., Smith, B., and Murphy, G. (1996). The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A. and initiates autoproteolytic activation. J. Biol. Chem. 271, 17119-17123.
52. Zarkik, S., Decroly, E., Wattiez, R., Seidah, N.G., Burny, A., and Ruysschaert, J.-M. (1997). Comparative processing of bovine leukemia virus envelope glycoprotein gp72 by subtilisin/kexin-like mammalian convertases. FEBS Lett. 406, 205-210.
53. Zhou, A., Webb, G., Zhu, X., and Steiner, D.F. (1999). Proteolytic processing in the secretory pathway. J. Biol. Chem. 274, 20745-20748.
54. Zhou, Z., Apte, S.S., Soininen, R., Cao, R., Baaklini, G.Y., Rauser, R.W., Wang, J., Cao, Y., and Tryggvason, K. (2000). Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. USA 97, 4052-4057.
55. Zucker, S., Drews, M., Conner, C., Foda, H.D., DeClerck, Y.A., Langley, K.E., Bahou, W.F., Docherty, A.J.P., and Cao, J. (1998). Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (M.T1-M.M.P). J. Biol. Chem. 273, 1216-1222.